NuGen M.D. Receives Approval for its Netherlands Site to Manufacture Needle-Free Devices Under ISO 13485 QMS Certificate
yahoo.com
news
2022-10-18 10:30:00

TORONTO, ON / ACCESSWIRE / October 18, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce that it has received confirmation of its official certification for its wholly owned subsidiary European Pharma Group B.V. has received approval for the manufacturing of needle-free devices at its' site in the Netherlands.

The additional manufacturing site allows NuGen to better serve markets in Europe, the Middle East and the Americas with lower logistical costs as well as reduced trade barriers and supply chain uncertainty It also positions the company to utilize a well-established European supply chain for many of its critical components.
